Medical marijuana helps reduce the frequency and severity of muscle spasms and ease stiffness. Patients experience more freedom of movement, calming of the frequent urge to urinate, and better sleep.
Medical cannabis also acts as an analgesic, helping to relieve pain and inflammation.
The American Academy of Neurology now publicly acknowledges marijuana’s potential to treat multiple sclerosis (MS), writing:
“Strong evidence shows that oral cannabis extract lessens patients’ reported symptoms of spasticity. It also lessens the pain caused by spasticity.”
The National Multiple Sclerosis Society supports the Academy’s position, adding:
“The Society supports advancing research to better understand the benefits and potential risks of marijuana and its derivatives as a treatment for MS.”
Before purchasing marijuana from a Florida medical marijuana treatment center (MMTC) – or dispensary – patients must first qualify for a medical marijuana certification; CannaMD provides qualified patients with the state-required recommendation to complete this process.
According to Florida state law, patients suffering from multiple sclerosis may qualify for medical marijuana treatment.
Patients can see if they qualify for free by completing a brief form or calling 1 (855) 420-9170.
For additional information on multiple sclerosis, please see CannaMD‘s Multiple Sclerosis Patient Resource Page.
CannaMD welcomes the opportunity to connect with fellow physicians and facilitate medical cannabis care.
For additional information, including how to refer multiple sclerosis patients and request complementary referral cards, please visit CannaMD‘s Physician Resource Page.
While the list below is not exhaustive, we hope you will enjoy the following primary source articles reviewing multiple sclerosis and marijuana research:
CannaMD is committed to fostering evidence-based discussion of medical cannabis research. Browse our blog and follow CannaMD on Facebook for breaking news!
Stay informed with the CannaMD newsletter!